Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules
MEDIA RELEASE
CIMERLI®*, a ranibizumab biosimilar, is interchangeable with LUCENTIS®** (ranibizumab-injection) for ...
MELBOURNE, Australia, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Pepperstone, a globally recognised Forex (FX) and Contracts for Difference (CFD) broker, announces an exciting partnership with the Asian Footba...
